To deepen our understanding, we reviewed the literature and validated the major related targets of anti-inflammatory, anti-EMT and anti-fibrosis treatment of CKD, such as ANGPTL4, FGFR1, SIRT3 and GR. Here, FGFR1 is linked to chronic kidney disease.